We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Findings Explain How Tumors Guide New Blood Vessel Formation

By LabMedica International staff writers
Posted on 15 Jul 2015
Print article
Image: Without angiogenesis a tumor cannot grow beyond a limited size (Photo courtesy of Cancer Research UK/Wikimedia Commons).
Image: Without angiogenesis a tumor cannot grow beyond a limited size (Photo courtesy of Cancer Research UK/Wikimedia Commons).
Tumors must generate new blood vessels in order to grow, and a recent paper described a novel Rho-family GTPase activation cascade that was required for the generation of the endothelial cell filopodial protrusions that are necessary for the tubule remodeling that forms the lumen through which the blood will flow.

During the process of new blood vessel formation or angiogenesis, enzymes known as Rho-GTPases influence endothelial cell migration and cell-to-cell adhesion. However, it is not known whether they control formation of vessel lumens, which are essential for blood flow. To clarify this point, investigators at the University of Leeds (United Kingdom) worked with mouse models that allowed them to manipulate levels of enzyme expression during VEGF (vascular endothelial growth factor)-dependent angiogenesis.

They reported in the July 1, 2015, online edition of the journal Nature Communications that lumen formation required early cytoskeletal remodeling and lateral cell–cell contacts, mediated through the RAC1 guanine nucleotide exchange factor (GEF) DOCK4 (dedicator of cytokinesis 4). DOCK family proteins contribute to cell signaling by activating G proteins of the Rho family, such as Rac and Cdc42. Dock4 dependent Rac activation regulates reorganization of the cytoskeleton and was known to lead to the formation of membrane protrusions, which are a crucial step in neuronal development and cell migration.

The investigators showed for the first time that DOCK4 signaling was necessary in angiogenesis for lateral filopodial protrusions and tubule remodeling prior to lumen formation, whereas proximal, tip filopodia persisted in the absence of DOCK4.

Senior author Dr. George Mavria, professor of medicine at the University of Leeds, said, “The finding gives an important indicator of how the protein affects the growth of secondary breast tumors in the brain. The discovery could also enable experts to predict which patients might be at risk of their breast cancer spreading, and develop drugs to prevent the growth of secondary tumors. We want to understand how these tumors form and grow, but we still need to do more research to stop these tumors growing altogether.”

Related Links:

University of Leeds 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.